235 related articles for article (PubMed ID: 30119271)
1. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management.
Singh MK; Das BK; Choudhary S; Gupta D; Patil UK
Biomed Pharmacother; 2018 Oct; 106():991-1002. PubMed ID: 30119271
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.
Noureddin M; Rinella ME
Clin Liver Dis; 2015 May; 19(2):361-79. PubMed ID: 25921668
[TBL] [Abstract][Full Text] [Related]
3. The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives.
Facciorusso A
Curr Diabetes Rev; 2013 Sep; 9(5):382-6. PubMed ID: 23845075
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?
Gao C; Yao SK
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):465-73. PubMed ID: 19822488
[TBL] [Abstract][Full Text] [Related]
7. Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
Hsieh MH; Kao TY; Hsieh TH; Kao CC; Peng CY; Lai HC; Chuang PH; Kao JT
PLoS One; 2020; 15(12):e0244293. PubMed ID: 33382703
[TBL] [Abstract][Full Text] [Related]
8. Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; Sanchez W
Am J Gastroenterol; 2013 Jun; 108(6):881-91; quiz 892. PubMed ID: 23381014
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
10. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
Das BK; Choukimath SM; Gadad PC
Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
12. Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back.
Yilmaz Y; Colak Y; Kurt R; Senates E; Eren F
Tumori; 2013; 99(1):10-6. PubMed ID: 23548993
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Mellitus and Risk of Hepatocellular Carcinoma.
Li X; Wang X; Gao P
Biomed Res Int; 2017; 2017():5202684. PubMed ID: 29379799
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives.
Vrachnis N; Iavazzo C; Iliodromiti Z; Sifakis S; Alexandrou A; Siristatidis C; Grigoriadis C; Botsis D; Creatsas G
Arch Gynecol Obstet; 2016 Feb; 293(2):239-46. PubMed ID: 26338721
[TBL] [Abstract][Full Text] [Related]
15. Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.
Li Q; Xu H; Sui C; Zhang H
Clin Res Hepatol Gastroenterol; 2022 Feb; 46(2):101781. PubMed ID: 34332136
[TBL] [Abstract][Full Text] [Related]
16. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ; Moss RA
Postgrad Med; 2014 Oct; 126(6):106-18. PubMed ID: 25414939
[TBL] [Abstract][Full Text] [Related]
18. Association between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort Study.
Lin CM; Huang HL; Chu FY; Fan HC; Chen HA; Chu DM; Wu LW; Wang CC; Chen WL; Lin SH; Ho SY
PLoS One; 2015; 10(5):e0125421. PubMed ID: 25978841
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus and metformin in hepatocellular carcinoma.
Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
[TBL] [Abstract][Full Text] [Related]
20. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.
Hessheimer AJ; Forner A; Varela M; Bruix J
Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1239-44. PubMed ID: 20505515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]